Aspirin-Based Carbon Dots, a Good Biocompatibility of Material Applied for Bioimaging and Anti-Inflammation

ACS Applied Materials and Interfaces

Volumn 8, Issue 48, 2016, Pages 32706-32716

  Xu, Xiaowei ^a,b   Zhang, Kai ^b   Zhao, Liang ^a   Li, Chen ^a   Bu, Wenhuan ^a   Shen, Yuqin ^a   Gu, Zhongyi ^a   Chang, Bei ^a   Zheng, Changyu ^c   Lin, Chongtao ^a   Sun, Hongchen ^a,b   Yang, Bai ^b  

^a JILIN UNIVERSITY   (China)

^b Jilin University   (China)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

anti inflammation; aspirin; biocompatibility; bioimaging; carbon dots

Indexed keywords

BIOCOMPATIBILITY; BODY FLUIDS; FLUORESCENCE; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PATHOLOGY; TOXICITY;

ANTI-INFLAMMATION; ANTI-INFLAMMATORY EFFECTS; ASPIRIN; BIO-IMAGING; CARBON DOTS; CARBON NANO-MATERIALS; MICROWAVE-ASSISTED METHODS; QUANTITATIVE POLYMERASE CHAIN REACTION;

POLYMERASE CHAIN REACTION;

ACETYLSALICYLIC ACID; BIOMATERIAL; CARBON; FLUORESCENT DYE; NONSTEROID ANTIINFLAMMATORY AGENT; QUANTUM DOT;

ANIMAL; BONE MARROW CELL; CHEMICALLY INDUCED; CHEMISTRY; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG EFFECT; HELA CELL LINE; HUMAN; INFLAMMATION; KB CELL LINE; MALE; MOUSE; NUDE MOUSE; PROCEDURES; RANDOMIZATION; RAW 264.7 CELL LINE; STROMA CELL; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CARBON; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; HELA CELLS; HUMANS; INFLAMMATION; KB CELLS; MALE; MICE; MICE, NUDE; QUANTUM DOTS; RANDOM ALLOCATION; RATS, WISTAR; RAW 264.7 CELLS; STROMAL CELLS;

EID: 85002603726     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.6b12252     Document Type: Article

References (56)

1. Xu, X. Y.; Ray, R.; Gu, Y. L.; Ploehn, H. J.; Gearheart, L.; Raker, K.; Scrivens, W. A. Electrophoretic Analysis and Purification of Fluorescent Single-Walled Carbon Nanotube Fragments J. Am. Chem. Soc. 2004, 126, 12736-12737 10.1021/ja040082h
2. Liu, C. J.; Zhang, P.; Zhai, X. Y.; Tian, F.; Li, W. C.; Yang, J. H.; Liu, Y.; Wang, H. B.; Wang, W.; Liu, W. G. Nano-Carrier for Gene Delivery and Bioimaging Based on Carbon Dots with PEI-Passivation Enhanced Fluorescence Biomaterials 2012, 33, 3604-3613 10.1016/j.biomaterials.2012.01.052
3. Zhao, Q. L.; Zhang, Z. L.; Huang, B. H.; Peng, J.; Zhang, M.; Pang, D. W. Facile Preparation of Low Cytotoxicity Fluorescent Carbon Nanocrystals by Electrooxidation of Graphite Chem. Commun. 2008, 44, 5116-5118 10.1039/b812420e
4. Peng, H.; Travas-Sejdic, J. Simple Aqueous Solution Route to Luminescent Carbogenic Dots from Carbohydrates Chem. Mater. 2009, 21, 5563-5565 10.1021/cm901593y
5. Zhang, Y. Q.; Ma, D. K.; Zhuang, Y.; Zhang, X.; Chen, W.; Hong, L. L.; Yan, Q. X.; Yu, K.; Huang, S. M. One-Pot Synthesis of N-Doped Carbon Dots with Tunable Luminescence Properties J. Mater. Chem. 2012, 22, 16714-16718 10.1039/c2jm32973e
6. Wang, W.; Li, Y. M.; Cheng, L.; Cao, Z. Q.; Liu, W. G. Water-Soluble and Phosphorus-Containing Carbon Dots with Strong Green Fluorescence for Cell Labeling J. Mater. Chem. B 2014, 2, 46-48 10.1039/C3TB21370F
7. Ding, C. Q.; Zhu, A. W.; Tian, Y. Functional Surface Engineering of C-Dots for Fluorescent Biosensing and In Vivo Bioimaging Acc. Chem. Res. 2014, 47, 20-30 10.1021/ar400023s
8. Nurunnabi, M.; Khatun, Z.; Huh, K. M.; Park, S. Y.; Lee, D. Y.; Cho, K. J.; Lee, Y. K. In Vivo Biodistribution and Toxicology of Carboxylated Graphene Quantum Dots ACS Nano 2013, 7, 6858-6867 10.1021/nn402043c
9. Huang, X. L.; Zhang, F.; Zhu, L.; Choi, K. Y.; Guo, N.; Guo, J. X.; Tackett, K.; Anilkumar, P.; Liu, G.; Quan, Q. M.; Choi, H. S.; Niu, G.; Sun, Y. P.; Lee, S.; Chen, X. Y. Effect of Injection Routes on the Biodistribution, Clearance, and Tumor Uptake of Carbon Dots ACS Nano 2013, 7, 5684-5693 10.1021/nn401911k
10. Wu, C. Y.; Wang, C.; Han, T.; Zhou, X. J.; Guo, S. W.; Zhang, J. Y. Insight into the Cellular Internalization and Cytotoxicity of Graphene Quantum Dots Adv. Healthcare Mater. 2013, 2, 1613-1619 10.1002/adhm.201300066
11. Zhu, S. J.; Zhang, J. H.; Qiao, C. Y.; Tang, S. J.; Li, Y. F.; Yuan, W. J.; Li, B.; Tian, L.; Liu, F.; Hu, R.; Gao, H. N.; Wei, H. T.; Zhang, H.; Sun, H. C.; Yang, B. Strongly Green-Photoluminescent Graphene Quantum Dots for Bioimaging Applications Chem. Commun. 2011, 47, 6858-6860 10.1039/c1cc11122a
12. Tao, H. Q.; Yang, K.; Ma, Z.; Wan, J. M.; Zhang, Y. J.; Kang, Z. H.; Liu, Z. In Vivo NIR Fluorescence Imaging, Biodistribution, and Toxicology of Photoluminescent Carbon Dots Produced from Carbon Nanotubes and Graphite Small 2012, 8, 281-290 10.1002/smll.201101706
13. Lee, H. U.; Park, S. Y.; Park, E. S.; Son, B.; Lee, S. C.; Lee, J. W.; Lee, Y. C.; Kang, K. S.; Kim, M. I.; Park, H. G.; Choi, S.; Huh, Y. S.; Lee, S. Y.; Lee, K. B.; Oh, Y. K.; Lee, J. Photoluminescent Carbon Nanotags from Harmful Cyanobacteria for Drug Delivery and Imaging in Cancer Cells Sci. Rep. 2014, 4, 4665-4671 10.1038/srep04665
14. Sun, Y. P.; Wang, X.; Lu, F.; Cao, L.; Meziani, M. J.; Luo, P. G.; Gu, L.; Veca, L. M. Doped Carbon Nanoparticles as a New Platform for Highly Photoluminescent Dots J. Phys. Chem. C 2008, 112, 18295-18298 10.1021/jp8076485
15. Wang, X.; Cao, L.; Lu, F. S.; Meziani, M. J.; Li, H. T.; Qi, G.; Zhou, B.; Harruff, B. A.; Kermarrec, F.; Sun, Y. P. Photoinduced Electron Transfers with Carbon Dots Chem. Commun. 2009, 45, 3774-3776 10.1039/b906252a
16. Lu, J.; Yang, J. X.; Wang, J.; Lim, A.; Wang, S.; Loh, K. P. One-Pot Synthesis of Fluorescent Carbon Nanoribbons, Nanoparticles, and Graphene by the Exfoliation of Graphite in Ionic Liquids ACS Nano 2009, 3, 2367-2375 10.1021/nn900546b
17. Bourlinos, A. B.; Stassinopoulos, A.; Anglos, D.; Zboril, R.; Karakassides, M.; Giannelis, E. P. Surface Functionalized Carbogenic Quantum Dots Small 2008, 4, 455-458 10.1002/smll.200700578
18. Tian, L.; Ghosh, D.; Chen, W.; Pradhan, S.; Chang, X. J.; Chen, S. W. Nanosized Carbon Particles from Natural Gas Soot Chem. Mater. 2009, 21, 2803-2809 10.1021/cm900709w
19. Han, B. F.; Wang, W. X.; Wu, H. Y.; Fang, F.; Wang, N. Z.; Zhang, X. J.; Xu, S. K. Polyethyleneimine Modified Fluorescent Carbon Dots and Their Application in Cell Labeling Colloids Surf., B 2012, 100, 209-214 10.1016/j.colsurfb.2012.05.016
20. 2 for Cell Imaging and Drug Release J. Mater. Chem. 2012, 22, 14403-14409 10.1039/c2jm32206d
21. De, B.; Karak, N. A Green and Facile Approach for the Synthesis of Water Soluble Fluorescent Carbon Dots from Banana Juice RSC Adv. 2013, 3, 8286-8290 10.1039/c3ra00088e
22. Zhu, S. J.; Meng, Q. N.; Wang, L.; Zhang, J. H.; Song, Y. B.; Jin, H.; Zhang, K.; Sun, H. C.; Wang, H. Y.; Yang, B. Highly Photoluminescent Carbon Dots for Multicolor Patterning, Sensors, and Bioimaging Angew. Chem., Int. Ed. 2013, 52, 3953-3957 10.1002/anie.201300519
23. Sahu, S.; Behera, B.; Maiti, T. K.; Mohapatra, S. Simple One-Step Synthesis of Highly Luminescent Carbon Dots from Orange Juice: Application as Excellent Bio-Imaging Agents Chem. Commun. 2012, 48, 8835-8837 10.1039/c2cc33796g
24. Zhou, J. J.; Sheng, Z. H.; Han, H. Y.; Zou, M. Q.; Li, C. X. Facile Synthesis of Fluorescent Carbon Dots Using Watermelon Peel as a Carbon Source Mater. Lett. 2012, 66, 222-224 10.1016/j.matlet.2011.08.081
25. Wu, Z. L.; Zhang, P.; Gao, M. X.; Liu, C. F.; Wang, W.; Leng, F.; Huang, C. Z. One-Pot Hydrothermal Synthesis of Highly Luminescent Nitrogen-Doped Amphoteric Carbon Dots for Bioimaging from Bombyx Mori Silk-Natural Proteins J. Mater. Chem. B 2013, 1, 2868-2873 10.1039/c3tb20418a
26. Guo, C. X.; Xie, J.; Wang, B.; Zheng, X.; Yang, H. B.; Li, C. M. A New Class of Fluorescent-Dots: Long Luminescent Lifetime Bio-Dots Self-Assembled from DNA at Low Temperatures Sci. Rep. 2013, 3, 2957-2962 10.1038/srep02957
27. Vane, J. R.; Botting, R. M. The Mechanism of Action of Aspirin Thromb. Res. 2003, 110, 255-258 10.1016/S0049-3848(03)00379-7
28. Wallace, J. L.; Reuter, B.; Cicala, C.; McKnight, W.; Grisham, M. B.; Cirino, G. Novel Nonsteroidal Anti-Inflammatory Drug Derivatives with Markedly Reduced Ulcerogenic Properties in the Rat Gastroenterology 1994, 107, 173-179 10.1016/0016-5085(94)90074-4
29. Al-Swayeh, O.; Clifford, R.; Del Soldato, P.; Moore, P. A Comparison of the Anti-Inflammatory and Anti-Nociceptive Activity of Nitroaspirin and Aspirin Br. J. Pharmacol. 2000, 129, 343-350 10.1038/sj.bjp.0703064
30. Stegeman, I.; Bossuyt, P. M.; Yu, T.; Boyd, C.; Puhan, M. A. Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis PLoS One 2015, 10, e0127194 10.1371/journal.pone.0127194
31. Ratnasinghe, L. D.; Graubard, B. I.; Kahle, L.; Tangrea, J. A.; Taylor, P. R.; Hawk, E. Aspirin Use and Mortality from Cancer in a Prospective Cohort Study Anticancer Res. 2004, 24, 3177-3184
32. Rothwell, P. M.; Fowkes, F. G. R.; Belch, J. F. F.; Ogawa, H.; Warlow, C. P.; Meade, T. W. Effect of Daily Aspirin on Long-Term Risk of Death due to Cancer: Analysis of Individual Patient Data from Randomised Trials Lancet 2011, 377, 31-41 10.1016/S0140-6736(10)62110-1
33. Fang, J.; George, M. G.; Gindi, R. M.; Hong, Y. L.; Yang, Q. H.; Ayala, C.; Ward, B. W.; Loustalot, F. Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012) Am. J. Cardiol. 2015, 115, 895-900 10.1016/j.amjcard.2015.01.014
34. Sutcliffe, P.; Connock, M.; Gurung, T.; Freeman, K.; Johnson, S.; Kandala, N. B.; Grove, A.; Gurung, B.; Morrow, S.; Clarke, A. Aspirin for Prophylactic Use in the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review and Overview of Reviews Health Technol. Assess. 2013, 17, 1-253 10.3310/hta17430
35. Baker, S. N.; Baker, G. A. Luminescent Carbon Nanodots: Emergent Nanolights Angew. Chem., Int. Ed. 2010, 49, 6726-6744 10.1002/anie.200906623
36. Vane, J. R.; Botting, R. M. Mechanism of Action of Nonsteroidal Anti-Inflammatory Drugs Am. J. Med. 1998, 104, 2S-8S 10.1016/S0002-9343(97)00203-9
37. Smith, W. L. The Eicosanoids and Their Biochemical Mechanisms of Action Biochem. J. 1989, 259, 315-324 10.1042/bj2590315
38. Vane, J.; Botting, R. Inflammation and the Mechanism of Action of Anti-Inflammatory Drugs FASEB J. 1987, 1, 89-96
39. DeWitt, D. L.; El-Harith, E. A.; Kraemer, S. A.; Andrews, M. J.; Yao, E. F.; Armstrong, R. L.; Smith, W. L. The Aspirin and Heme-Binding Sites of Ovine and Murine Prostaglandin Endoperoxide Synthases J. Biol. Chem. 1990, 265, 5192-5198
40. Roth, G. J.; Majerus, P. W. The Mechanism of the Effect of Aspirin on Human Platelets. I. Acetylation of a Particulate Fraction Protein J. Clin. Invest. 1975, 56, 624-632 10.1172/JCI108132
41. Kalgutkar, A. S. Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2 Science 1998, 280, 1268-1270 10.1126/science.280.5367.1268
42. Li, X. M.; Rui, M. C.; Song, J. Z.; Shen, Z. H.; Zeng, H. B. Carbon and Graphene Quantum Dots for Optoelectronic and Energy Devices: A Review Adv. Funct. Mater. 2015, 25, 4929-4947 10.1002/adfm.201501250
43. Chen, Y. H.; Zheng, M. T.; Xiao, Y.; Dong, H. W.; Zhang, H. R.; Zhuang, J. L.; Hu, H.; Lei, B. F.; Liu, Y. L. A Self-Quenching-Resistant Carbon-Dot Powder with Tunable Solid-State Fluorescence and Construction of Dual-Fluorescence Morphologies for White Light-Emission Adv. Mater. 2016, 28, 312 10.1002/adma.201503380
44. Miles, C. I.; Schenk, G. H. Fluorescence of Acetylsalicylic Acid in Solution and Its Measurement in Presence of Salicylic Acid Anal. Chem. 1970, 42, 656-659 10.1021/ac60288a032
45. Petros, R. A.; DeSimone, J. M. Strategies in The Design of Nanoparticles for Therapeutic Applications Nat. Rev. Drug Discovery 2010, 9, 615-627 10.1038/nrd2591
46. Lu, Y. C.; Yeh, W. C.; Ohashi, P. S. LPS/TLR4 Signal Transduction Pathway Cytokine+ 2008, 42, 145-151 10.1016/j.cyto.2008.01.006
47. Hawkins, D. L.; MacKay, R. J.; MacKay, S. L.; Moldawer, L. L. Human Interleukin 10 Suppresses Production of Inflammatory Mediators by LPS-Stimulated Equine Peritoneal Macrophages Vet. Immunol. Immunopathol. 1998, 66, 1-10 10.1016/S0165-2427(98)00181-0
48. Shackelford, R. E.; Alford, P. B.; Xue, Y.; Thai, S. F.; Adams, D. O.; Pizzo, S. Aspirin Inhibits Tumor Necrosis Factor-α Gene Expression in Murine Tissue Macrophages Mol. Pharmacol. 1997, 52, 421-429 10.1124/mol.52.3.421
49. Turnbull, C. M.; Marcarino, P.; Sheldrake, T. A.; Lazzarato, L.; Cena, C.; Fruttero, R.; Gasco, A.; Fox, S.; Megson, I. L.; Rossi, A. G. A Novel Hybrid Aspirin-NO-Releasing Compound Inhibits TNFalpha Release from LPS-Activated Human Monocytes and Macrophages J. Inflammation (London, U. K.) 2008, 5, 12 10.1186/1476-9255-5-12
50. Zhang, T. T.; Sun, L.; Liu, R.; Zhang, D.; Lan, X.; Huang, C.; Xin, W. Y.; Wang, C.; Zhang, D. M.; Du, G. H. A Novel Naturally Occurring Salicylic Acid Analogue Acts as an Anti-Inflammatory Agent by Inhibiting Nuclear Factor-kappaB Activity in RAW264.7 Macrophages Mol. Pharmaceutics 2012, 9, 671-677 10.1021/mp2003779
51. West, M. A.; Seatter, S. C.; Bellingham, J.; Clair, L. Mechanisms of Reprogrammed Macrophage Endotoxin Signal Transduction after Lipopolysaccharide Pretreatment Surgery 1995, 118, 220-228 10.1016/S0039-6060(05)80327-7
52. Wei, J.; Pan, X. D.; Pei, Z.; Wang, W. M.; Qiu, W. S.; Shi, Z. H.; Xiao, G. M. The Beta-Lactam Antibiotic, Ceftriaxone, Provides Neuroprotective Potential via Anti-Excitotoxicity and Anti-Inflammation Response in a Rat Model of Traumatic Brain Injury J. Trauma Acute Care Surg. 2012, 73, 654-660 10.1097/TA.0b013e31825133c0
53. Melzer, N.; Meuth, S. G.; Torres-Salazar, D.; Bittner, S.; Zozulya, A. L.; Weidenfeller, C.; Kotsiari, A.; Stangel, M.; Fahlke, C.; Wiendl, H. A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis PLoS One 2008, 3, e3149 10.1371/journal.pone.0003149
54. Zanardo, R. C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J. L. Hydrogen Sulfide Is an Endogenous Modulator of Leukocyte-Mediated Inflammation FASEB J. 2006, 20, 2118-2120 10.1096/fj.06-6270fje
55. Di Rosa, M. Biological Properties of Carrageenan J. Pharm. Pharmacol. 1972, 24, 89-102 10.1111/j.2042-7158.1972.tb08940.x
56. Wang, D. Z.; DuBois, R. N. Pro-Inflammatory Prostaglandins and Progression of Colorectal Cancer Cancer Lett. 2008, 267, 197-203 10.1016/j.canlet.2008.03.004